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ABSTRACT We have developed a method to analyze the
relative contributions of pre- and postsynaptic actions of a
particular gene product in neurons in culture and potentially
in slices using adenovirus-mediated gene transfer. A recom-
binant virus directed the expression of both a GFP reporter
protein and TrkB.T1, a C-terminal truncated dominant neg-
ative TrkB neurotrophin receptor. When expressed in the
presynaptic cell at synapses between embryonic hippocampal
neurons in culture, the dominant negative TrkB.T1 inhibited
two forms of synaptic potentiation induced by the neurotro-
phin brain-derived neurotrophic factor (BDNF): (i) greater
evoked synaptic transmission and (ii) higher frequency of
spontaneous miniature synaptic currents. These inhibition
effects are not seen if the transgene is expressed only in the
postsynaptic cell. We conclude that BDNF-TrkB signal trans-
duction in the presynaptic terminal leads to both types of
potentiation and is therefore the primary cause of synaptic
enhancement by BDNF in these neurons.
The neurotrophins, including nerve growth factor, brain-
derived neurotrophic factor (BDNF), and neurotrophin-3,
have recently been shown to enhance transmission at central
and peripheral synapses within minutes of application (1–6).
Neurotrophins exert their effects on synaptic strength by
interacting with the Trk family of receptor Tyr kinases (1, 3, 5,
7, 8). In experiments reporting the effect of BDNF on en-
hancing synaptic transmission in cultured cells, the data have
been interpreted to favor a primarily presynaptic (refs. 1 and
2; Y.-X.L., Y. Zhang, H.A.L., E.M.S., and N.D., unpublished
data) or a primarily postsynaptic (4) site for the BDNF/TrkB
interaction. The results of Kang and Schuman (in acute
hippocampal slices from adult rats) (3, 9) are most plausibly
interpreted as indicating both pre- and postsynaptic actions.
It is therefore of considerable interest to develop a method
for inhibiting TrkB receptors selectively, either pre- or postsyn-
aptically. We describe such a method and report its use to
determine that the primary site of BDNF action for synapses
between E18 hippocampal neurons in culture is with presyn-
aptic TrkB receptors.
MATERIALS AND METHODS
Cell Culture. Pregnant Wistar rats were euthanized by
inhalation of CO2, and embryos were immediately removed by
cesarean section. Hippocampi were rapidly removed under
stereomicroscopic observation under sterile conditions, cut
into 1-mm pieces, and digested with 0.25% trypsin/0.25 mg/ml
DNase (Sigma) in Hanks’ balanced salt solution without
calcium or magnesium (GIBCO) at 36°C for 15 min. The pieces
were then gently rinsed in Hanks’ balanced salt solution,
washed twice in plating medium [Neurobasal with B27 sup-
plement (GIBCO), with 500 mM Glutamax (GIBCO), and 25
mM glutamate], and gently triturated in 1 ml of plating medium
with five passes through the 0.78-mm opening of a blue tip of
a P-1000 Pipetman. Suspended cells were decanted and the
remaining pieces were triturated once more. Cell suspensions
were gravity filtered through a 70-mm nylon mesh (Falcon) to
remove large debris and centrifuged for 2 min at 150 3 g.
Pellets were suspended by gentle trituration as described
above. Approximately 35,000 cells were plated in an area 15
mm in diameter at the middle of a 35-mm plastic culture dish
(Corning) that had been coated with poly-D-lysine and lami-
nin. Cultures were maintained at 36°C in a 5% CO2 incubator.
After the plated neurons had settled, a hippocampal glial cell
layer, plated on a Thermonox slide and prepared essentially as
described by Goslin and Banker (10), was placed over the
culture and maintained there until the culture was used for
viral infection. About 2 days later, one-half of the medium over
the neurons was replaced with culture medium (Neurobasal
with B27 supplement and 500 mM Glutamax), to which 4 mM
cytosine arabinoside had been added. One-half of the medium
was replaced weekly thereafter. Viral infection and recording
was done after about 2 wk in culture.
Electrophysiological Recording. Prior to recording, a dish
was removed from the incubator and the culture medium was
replaced with recording saline: NaCl, 110 mM; KCl, 5.4 mM;
CaCl2, 1.8 mM; MgCl2, 0.8 mM; Hepes, 10 mM; D-glucose, 10
mM; and picrotoxin, 0.1 mM, titrated to pH 7.4 with NaOH,
and osmolarity was adjusted to 230 mOsmol with sucrose. Dual
or single whole-cell recordings were made at room tempera-
ture with pipettes pulled in four stages from 1.5-mm o.d. glass
capillary tubes (WPI, Sarasota, FL) with a P-80/PC micropi-
pette puller (Sutter Instruments, Novato, CA). Patch pipettes
were filled with a solution containing: potassium gluconate,
100 mM; CaCl2, 0.1 mM; EGTA, 1.1 mM; MgCl2, 5 mM;
Hepes, 10 mM; ATP, 3 mM; phosphocreatine, 3.0 mM; and
GTP, 0.3 mM, pH 7.2 (215 mOsmol). Ionic currents or voltages
were measured with patch-clamp amplifiers (Axopatch 200
and Axopatch-1D; Axon Instruments, Foster City, CA), fil-
tered at 2 kHz, digitized at 10 kHz, and recorded on a
computer (pCLAMP 6; Axon Instruments) and monitored on
both a storage oscilloscope and a chart recorder. Synaptic
activities were simultaneously recorded digitally at 9 kHz on
pulse–code-modulated magnetic tape (Instrutech VR-100;
Instrutech, Great Neck, NY) for off-line analysis. The series
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resistance was monitored by measuring the instantaneous
current in response to a 5-mV voltage step command. Results
were discarded if the series resistance changed by more than
10% during the course of an experiment.
In the presence of 100 nM tetrodotoxin, miniature excita-
tory postsynaptic currents (mEPSCs) were recorded. The
mEPSCs were detected and measured by FETCHEX in the
pCLAMP6 series (Axon Instruments). Threshold detection
levels were between 3 and 10 pA (with lower series resistance,
the size of both the noise and signal was larger, thus requiring
a higher detection threshold ('10 pA). The selected threshold
level remained constant for the duration of the experiment. All
events larger than this level were included if they had rise times
,3 ms and had a waveform similar to that of the evoked EPSC.
Events that began during the decay phase of a previous event
were not included in the amplitude measurements but were
included in the frequency measurements. The frequency of
mEPSCs was measured over 30-s intervals. For dual whole-cell
recording, both presynaptic and postsynaptic cells were voltage
clamped at a holding potential of 270 mV. When the presyn-
aptic neuron was stimulated with an 8-ms positive voltage step
(to 220 mV or 210 mV), a large (several nA) transient inward
current was activated in the presynaptic cell and an EPSC in
the postsynaptic neuron. Depolarizing currents were injected
every 15 s, except in experiments on reciprocally connected
neurons. For that case, the time interval was 12 s, and pre- and
postsynaptic neurons were switched every minute. We studied
only monosynaptic EPSCs as judged by two criteria: (i) short
and constant latency (,5 ms) and (ii) a waveform with a single
peak (11). Values reported in the text and figure legends are
mean 6 SEM. Statistical comparisons were performed using
paired and unpaired t tests to analyze differences within an
experiment and between experimental groups, respectively. P
values reported in brackets in the text represent significance
levels for paired t tests performed on pre- versus post-BDNF
values. P values .0.05 were considered not significant (NS)
and are indicated.
Our general methods for preparing recombinant Ad viruses,
including the specific pAC plasmid used as an adenovirus
transfer plasmid and the viruses with which they are recom-
bined, have been described (12). The TrkB cDNA was a gift
from George Yancopoulos (Regeneron Pharmaceuticals, Inc.,
Tarrytown, NY). It contained sequences from nucleotides 253
to 3631 of the GenBank Sequence (accession no. M55291),
with the initiating ATG at 664 and the termination codon at
3127. The TrkB.T1 cDNA was a gift from Tony Hunter (Salk
Institute, San Diego, CA) and has been described (13). Each
cDNA was cloned in the pAC transfer vector. The trkB cDNA
was then recombined with AdPacI and the TrkB.T1 cDNA
with Ad PacI-GFP as described (12). To assess the dominant
negative activity of Ad-TrkB.T1-GFP, Chinese hamster ovary
cells were coinfected with 1 3 107 plaque-forming units
(pfus)/ml of Ad-TrkB and 1 3 108 pfus/ml Ad-DE1-GFP or
Ad-TrkB.T1-GFP for 2 hr. Forty-eight hours later cells were
treated with 100 ng/ml BDNF for 15 min. Following BDNF
treatment, immunoprecipitation with a TrkB antibody (gift
from Andy Welcher, Amgen, Thousand Oaks, CA) was per-
formed followed by Western blot analysis with an anti-
phosphotyrosine antibody.
For electrophysiology experiments, E18 hippocampal neu-
rons were infected by either 3 3 107 or 3 3 108 pfus/ml
adenovirus (either Ad-DE1-GFP or Ad-TrkB.T1-GFP) for 2
hr in the absence of the glial overlayer. After 2 hr, the viral
suspension was diluted by 50% with culture medium and
infection was allowed to continue for an additional 12–16 hr.
Electrophysiological experiments were performed 24–48 hr
later.
RESULTS
To assess the relative contributions of pre- and postsynaptic
neurons to BDNF-induced potentiation in cultured hippocam-
pal neurons, we constructed an adenovirus vector, Ad-
TrkB.T1-GFP, expressing cDNAs for both a truncated TrkB
receptor (12–14) and a GFP reporter (Fig. 1a). Previous
studies show that this truncated TrkB receptor acts as a
dominant negative (15). We verified the dominant negative
activity of the Ad-TrkB.T1-GFP virus by examining its ability
to inhibit BDNF-induced phosphorylation of the TrkB recep-
tor. Chinese hamster ovary cells coinfected with two adeno-
viruses, one expressing TrkB (Ad-TrkB) and another contain-
ing the control virus (Ad-DE1-GFP) at a ratio of 1:10, exhib-
ited robust BDNF-induced TrkB phosphorylation (Fig. 1b). In
contrast, cells infected with Ad-TrkB and Ad-TrkB.T1-GFP
(ratio of 1:10) exhibited significantly reduced TrkB phosphor-
ylation (Fig. 1b), indicating that expression of the truncated
Trk receptor can inhibit the ability of full-length TrkB to
respond to BDNF. We believe that more complete T1-
mediated inhibition of TrkB phosphorylation likely occurs in
neurons, owing to the lower amounts of native, endogenous
TrkB.
The basic experimental design is illustrated at the top of
Figs. 2–5. Dual whole-cell recordings were made from two cells
that were close and appeared to be synaptically connected. For
dual whole-cell recording, both presynaptic and postsynaptic
cells were voltage clamped at a holding potential of 270 mV.
When the presynaptic neuron was stimulated with an 8-ms
positive voltage step (to 220 mV or 210 mV) every 15 s, an
inward current was induced in the presynaptic cell due to Na1
channel activation, and an EPSC was elicited in the postsyn-
aptic neuron (Fig. 2c, Lower and Upper, respectively). Only
FIG. 1. Ad-TrkB.T1-GFP inhibits BDNF-induced phosphorylation
of TrkB. (a) Viral constructs: In Ad-TrkB.T1-GFP, a truncated TrkB
receptor expression cassette was inserted into the E1 region of an
adenovirus vector containing a GFP expression cassette in the E3
region. In the control Ad-DE1-GFP, the GFP gene was inserted into
the E3 region of an adenovirus vector deleted in the E1 region. (b)
Antiphosphotyrosine blots of anti-TrkB immunoprecipitated fractions
from Chinese hamster ovary cells infected with Ad-TrkB and Ad-
DE1-GFP. The full-length TrkB receptor is detected near 130,000.
Treatment with Ad-TrkB.T1-GFP substantially reduced the amount of
phosphorylated TrkB receptor detected.
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monosynaptic EPSCs were studied. The criteria for recogniz-
ing monosynaptic EPSCs are given in Materials and Methods.
At the time the present work was initiated, we had already
observed (Y.-X.L., Y. Zhang, H.A.L., E.M.S., and N.D.,
unpublished data) that application of BDNF (100 ng/ml) to
synaptically connected pairs of cultured neurons results in a
rapid increase in evoked synaptic transmission. Typical results
are illustrated in Fig. 2 c–e. These observations were after
infection of both cells with the control virus Ad-DE1-GFP, but
identical results were observed for uninfected cells (data not
shown; Y.-X.L., Y. Zhang, H.A.L., E.M.S., and N.D., unpub-
lished data). Specifically, six of nine synaptically coupled pairs
of neurons exhibited BDNF-induced potentiation which did
not differ in magnitude or duration from our previous study of
uninfected neurons [mean percentage of baseline: 144.1 6
11.5%, P # 0.01 (n 5 9)] (Y.-X.L. et al., unpublished data).
To provide decisive results on pre- versus postsynaptic
actions, we conducted experiments in which only some of the
neurons in the culture were infected. A dish was infected with
Ad-TrkB.T1-GFP at a titer of either 3 3 107 or 3 3 108 pfus/ml,
FIG. 3. Ad-TrkB.T1-GFP infection of both pre- and postsynaptic
neurons prevents BDNF-induced potentiation of evoked synaptic
transmission. (a) Scheme of recording arrangement indicating that
whole-cell recordings were obtained from two synaptically connected
neurons, both infected with Ad-TrkB.T1-GFP. (b) Phase-contrast and
fluorescence images of GFP-expressing cells during recordings. (c)
Representative individual and averaged pre- and postsynaptic traces,
as in Fig. 2, showing EPSCs elicited before (CONTROL) and during
BDNF application. The mean EPSC amplitude before and after
BDNF application was 94.3 6 21.9 and 98.1 6 21.3 pA, respectively.
(d) Plot of EPSC amplitude in an exemplar experiment before, during,
and after BDNF application. (e) Percentage of potentiation (at 3 min
after the start of perfusion with BDNF) for each of the eight pairs
studied (E). r, mean and SEM.
FIG. 2. Infection by the control Ad-DE1-GFP reporter virus allows
BDNF-induced potentiation of evoked synaptic transmission. (a)
Scheme of recording arrangement indicating that whole-cell record-
ings were obtained from two synaptically connected neurons, both
expressing GFP. (b) Phase-contrast and fluorescence images of GFP-
expressing cells during recordings. (c) Representative voltage-clamp
currents in presynaptic (Lower) and postsynaptic (Upper) cells; the
postsynaptic traces show EPSCs. Recordings are shown before (Con-
trol) and during exposure to BDNF (3 min after the start of BDNF
perfusion). Traces labeled MEAN are averaged from eight consecu-
tive EPSCs before or after BDNF application. The EPSC amplitude
before and during BDNF application was 103.5 6 19.1 and 147.2 6
28.6 pA, respectively (mean 6 SEM). (d) Plot of EPSC amplitude in
an exemplar experiment before, during, and after BDNF application.
(e) Percentage of potentiation (at 3 min after start of perfusion with
BDNF) for each of the nine individual pairs studied (E). r, mean and
SEM.
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leading, respectively, to either a small or a large fraction of
infected neurons (i.e., expressing T1 and GFP). The effect of
adding BDNF on the evoked synaptic current or on the
minifrequency, both recorded in the postsynaptic cell, was then
observed.
Experiments like those shown in Fig. 3 were conducted on
cultures infected with Ad-TrkB.T1-GFP at the higher titer, so
that both members of a synaptically connected pair were
frequently infected. In contrast to the results with infection by
the control virus (Fig. 2), BDNF failed to enhance synaptic
transmission significantly in any of the dually infected neuron
pairs recorded (Fig. 3) [mean percentage of baseline: 107.3 6
2.9%, NS (n 5 8)]. The magnitude of potentiation observed in
T1-infected neurons was significantly less than in Ad-DE1-
GFP-infected neurons (P , 0.01). This finding indicates that
TrkB is required for BDNF to initiate synaptic potentiation
between cultured neurons, as has been observed in studies in
hippocampal slices (7, 8), but does not distinguish whether
presynaptic or postsynaptic TrkB receptors or both are re-
quired for this plasticity.
To determine whether BDNF signal transduction occurs
pre- or postsynaptically, we recorded from synaptically cou-
pled neurons in which either the pre- or postsynaptic cell was
infected with Ad-TrkB.T1-GFP and the synaptic partner was
uninfected. In such pairs in which the postsynaptic neuron was
infected with Ad-TrkB.T1-GFP, BDNF application produced
an increase in evoked synaptic responses comparable to that
observed in controls (Fig. 4 e and g) [mean percentage of
baseline: 132.1 6 9.9%, P # 0.05 (n 5 11)]. Seven of these 11
pairs exhibited a potentiation of at least 15% above baseline
FIG. 4. Infection of presynaptic, but not postsynaptic, neurons with Ad-TrkB.T1-GFP prevents BDNF induced potentiation of evoked synaptic
transmission. Whole-cell recordings were obtained from 26 pairs of synaptically connected neurons comprising one infected neuron (shown as green)
and one noninfected neuron (shown as clear). (a) Scheme of recording arrangement for 18 of the pairs. In seven pairs, the infected neuron was
presynaptic; in the other 11 pairs, the infected cell was postsynaptic. (b) Scheme of the recording arrangement for eight other pairs that were
reciprocally connected; depolarizing pulses were applied alternatively in each cell, eliciting EPSCs that were measured in the other cell. (c and d)
Phase-contrast and fluorescence images of exemplar fields during the recordings schematized in a and b, respectively. (e) Either the pre- (Pre-T1,
E) or postsynaptic (Post-T1, F) neuron was infected with Ad-TrkB.T1-GFP. When the infected neuron was postsynaptic BDNF potentiated the
evoked response. Interleaved recordings in which the infected neuron was now presynaptic, revealed that BDNF failed to potentiate evoked
transmission. The mean EPSC amplitude before and after BDNF application was 111.8 6 17.6 and 152.2 6 26.0 pA, respectively, for pairs with
Post-T1. The mean EPSC amplitude before and after BDNF application was 99.9 6 24.0 and 100.7 6 24.4 pA, respectively, for pairs with Pre-T1
neurons. (g) Percentage of potentiation (at 3 min after the start of BDNF perfusion) for each pair (E). r, mean and SEM. ( f) Plot of EPSC amplitude
for an exemplar experiment before, during, and after BDNF application for the reciprocally connected pairs schematized in b. During BDNF
application, transmission was potentiated when the infected neuron was postsynaptic (F, A3 B), but not when the infected neuron was presynaptic,
even though the tests were performed during interleaved 1-min intervals. The mean EPSC amplitude before and after BDNF application was 111.8 6
17.6 and 152.2 6 26.0 pA, respectively, for stimuli applied to the nonexpressing neuron and recorded postsynaptically in the T1-expressing neuron
(A 3 B). The mean EPSC amplitude before and after BDNF application was 99.9 6 24.0 and 100.7 6 24.4 pA, respectively, for stimuli applied
to the T-expressing neuron and recorded in the nonexpressing postsynaptic neuron (B3 A). (h) Mean percentage of potentiation (at 3 min after
start of BDNF perfusion) for each individual experiment with the reciprocally connected pairs.
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levels. In seven other pairs, only the presynaptic neuron was
infected with Ad-TrkB.T1-GFP; none of these pairs exhibited
significant potentiation (Fig. 4 e and g) [mean percentage of
baseline: 101.9 6 2.8%, NS (n 5 7)] (P # 0.05). These results
show that TrkB signaling in the presynaptic neuron is required
for BDNF-induced potentiation.
This conclusion is reinforced by an additional set of exper-
iments on neuron pairs that (i) fortuitously displayed recipro-
cal synaptic connectivity and (ii) comprised one uninfected
and one Ad-TrkB.T1-GFP-infected neuron. With this record-
ing arrangement, we monitored the strength of the synaptic
connection in both directions and hence determined the
effects of pre- versus postsynaptic T1 expression in the pair of
neurons. During 1-min intervals, we (i) alternately stimulated
the neuron expressing T1 (‘‘cell B’’) and recorded the response
in the uninfected cell (‘‘cell A’’) or (ii) stimulated cell B and
recorded the postsynaptic response in cell A (see Fig. 4). These
measurements were carried out before, during, and after
washout of applied BDNF. Similar to the previous set of
experiments, when the T1-expressing neuron was presynaptic
BDNF failed to produce synaptic enhancement (Fig. 4 f and h)
[mean percentage of baseline: 100.8 6 2.4%, NS (n 5 8)].
When the same T1-expressing cell was postsynaptic, however,
it usually (five of eight experiments) exhibited potentiated
EPSCs following application of BDNF (Fig. 4 f and h) [mean
percentage of baseline: 141.1 6 12.3%, P # 0.05 (n 5 8)]. The
magnitude of potentiation observed when the infected neuron
was postsynaptic was significantly greater than when it was
presynaptic (P # 0.05). These experiments add strength to the
conclusion that signaling occurs through presynaptic rather
than postsynaptic TrkB receptors.
Another potent effect of BDNF on hippocampal synaptic
transmission is the enhancement of the frequency, but not the
amplitude, of mEPSCs in cultured neurons (Y.-X.L., Y.
Zhang, H.A.L., E.M.S., and N.D., unpublished data). Al-
though increases in mEPSC frequency have traditionally been
interpreted as reflecting a presynaptic change (16), recent
studies (17–19) have suggested that the uncovering of previ-
ously silent postsynaptic receptors might represent a plausible
alternative interpretation. We have tested the synaptic locus of
BDNF signaling in mEPSC frequency enhancement by ex-
pressing T1 in either a postsynaptic or a presynaptic compart-
ment. In the first set of experiments, we examined transmission
for cases in which a single neuron expressing T1 (or GFP
alone) was surrounded by many uninfected neurons. We
obtained a whole-cell recording from the T1-expressing neu-
ron and monitored mEPSC frequency before and after the
application of BDNF. We found that BDNF still enhanced
mEPSC frequency when the postsynaptic neuron was infected
with Ad-TrkB.T1-GFP (Fig. 5 e and g) [mean percentage of
baseline: 194.0 6 10.6%, P # 0.001 (n 5 6)]. The enhancement
observed in postsynaptic T1-expressing neurons was indistin-
guishable from that observed when postsynaptic neurons were
infected with the reporter gene alone, Ad-DE1-GFP (Fig. 5g)
[mean percentage of baseline: 192.8 6 7.2%, P # 0.05 (n 5 6)].
In complementary experiments, we recorded from an un-
infected postsynaptic neuron innervated by many presynaptic
neurons infected with Ad-TrkB.T1-GFP (Fig. 5b). When many
of the presynaptic neurons were expressing T1, BDNF failed
to enhance frequency [mean percentage of baseline: 105.7 6
6.1%, NS (n 5 6)] (Fig. 5 f and h). In control experiments,
postsynaptic neurons innervated by presynaptic neurons ex-
pressing Ad-DE1-GFP exhibited robust BDNF-induced poten-
tiation of mEPSC frequency [mean percentage of baseline:
188.2 6 2.2%, P # 0.05 (n 5 6)]. The increase in mEPSC
frequency observed when presynaptic neurons were infected
with the control virus, Ad-DE1-GFP, was significantly greater
than that observed when presynaptic neurons were infected
with Ad-TrkB.T1-GFP (P # 0.05). These data demonstrate
that presynaptic but not postsynaptic TrkB is critical for
BDNF-induced increases in frequency.
In summary, the expression of a dominant negative TrkB in
either pre- or postsynaptic embryonic neurons shows that
applied BDNF transiently potentiates both evoked and spon-
taneous synaptic transmission by interacting with presynaptic
Trk B receptors.
DISCUSSION
Together with our previous results (Y.-X.L., Y. Zhang, H.A.L.,
E.M.S., and N.D., unpublished data), the data presented here
indicate that the primary synaptic action of BDNF in E18
hippocampal cultures is to augment presynaptic function.
BDNF does not appear to alter the size of miniature synaptic
events nor the size of the postsynaptic response to exogenous
glutamate (Y.-X.L., Y. Zhang, H.A.L., E.M.S., and N.D.,
unpublished data). We note that under somewhat different
FIG. 5. Expression of Ad-TrkB.T1-GFP in presynaptic but not
postsynaptic neurons inhibits BDNF-induced increases in mEPSC
frequency. (a and b) Schemes of recording arrangement indicating that
whole-cell recordings were obtained from single neurons that were
either (a) infected with Ad-TrkB.T1-GFP and innervated by many
uninfected neurons or (b) uninfected but innervated by many infected
neurons. (c and d) bright-field and fluorescence images of GFP-
expressing cells during recording schematized in a and b, respectively.
(e) Representative sweeps containing mEPSCs before, during, and
after BDNF application in an exemplar experiment schematized in a.
(g) Plot of mEPSC frequency before, during, and after BDNF appli-
cation in an experiment like that shown in e. The mean percentage of
control is expressed relative to values obtained from uninfected
cultures at 3 min after the start of BDNF perfusion. ( f) Representative
sweeps containing mEPSCs before, during, and after BDNF applica-
tion in an exemplar experiment schematized in b. (h) Plot of mEPSC
frequency before, during, and after BDNF application in an experi-
ments like that in f. Mean percentage of control is expressed relative
to values obtained from uninfected cultures at 3 min after the start of
BDNF perfusion.
10888 Neurobiology: Li et al. Proc. Natl. Acad. Sci. USA 95 (1998)
culture conditions, Levine et al. (4) report that postsynaptic
injection of the receptor Tyr kinase inhibitor, K252a, pre-
vented the synaptic action of BDNF. This experiment was
taken to indicate that the primary locus of action was postsyn-
aptic. The differing results may be due to differences in the
culture conditions; alternatively, it is possible that because
K252a is membrane permeant, it diffused from the injected
postsynaptic cell and affected the TrkB receptors or down-
stream Tyr kinases in the adjoining presynaptic membranes.
The effects of BDNF on synaptic transmission in slices from
adult rats clearly differ from those observed here for cultured
E18 neurons. In slices it has been observed that protein
synthesis, which is probably postsynaptic, is required for BD-
NF’s actions (9), while there is likely also a presynaptic change
in synaptic efficacy (3). In contrast, protein synthesis is not
required for BDNF’s actions on synaptic transmission in
cultured hippocampal neurons (Y.-X.L., Y. Zhang, H.A.L.,
E.M.S., and N.D., unpublished data). This difference in syn-
aptic locus in developing versus mature synapses cannot be
explained by the absence of TrkB in developing dendrites,
because we (H. R. Li, personal communication) and others
(20, 21) have observed TrkB in dendrites of cultured hip-
pocampal neurons. [Consistent with the results reported here,
we also observed immunostaining for TrkB in axonal projec-
tions (H. R. Li, personal communication)].
In the experiments of Schuman and Kang (3, 9), the
observed long-lasting enhancement of synaptic transmission
was produced by application of BDNF for about 20 min. When
we applied BDNF for 20 min to neurons in culture, synaptic
enhancement decayed slightly over the time period and recov-
ered to baseline within 10 min of washout (data not shown). In
effect, the results for the 20-min application of BDNF did not
substantially differ from those for 5-min applications.
We also wish to note that a full understanding of the
BDNF/TrkB interaction is important for the study of long-
term potentiation (LTP). Specifically, Kang et al. (8) showed
the function-blocking antibodies to TrkB caused a reduction in
LTP from about 20 min after tetanus. These effects suggest
that activity-dependent BDNF secretion plays a role in LTP.
Several other recent studies also demonstrate the importance
of the BDNF/TrkB interaction in LTP (22–24). Figurov et al.
(22) suggest that in part the BDNF effect on LTP is presyn-
aptic, as did Kang and Schuman (3) for the effect of BDNF on
synaptic transmission in adult slices.
Finally, we suggest that the method used here for analyzing
the relative pre- and postsynaptic effects of a particular gene
product in synaptic function will find many useful applications
in studies of synaptic function of neurons in culture and in
slices.
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